Real World Effectiveness of Eptinezumab in Participants With Migraine

NCT05284019 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

32

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to enrolment challenges.

Conditions

Migraine

Interventions

DRUG: Eptinezumab
DRUG: Erenumab
DRUG: Onabotulinumtoxin-A
DRUG: Fremanezumab
DRUG: Galcanezumab

Sponsor

H. Lundbeck A/S